1. Home
  2. NICE Guidance
  3. Health and social care delivery
  4. Emergency care

CytoSorb for reducing risk of bleeding during cardiac surgery

Medtech innovation briefing [MIB249] Published: 02 February 2021

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

Regulatory information

Regulatory information

CytoSorb is a CE‑marked class IIb medical device.


  • Next